scholarly journals Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma

2020 ◽  
Vol 26 ◽  
Author(s):  
Munire Yuemaier ◽  
Zhiqiang Zhou ◽  
Youxu Zhou ◽  
Chengwen Wu ◽  
Fei Li ◽  
...  
Keyword(s):  
Clinical Significance ◽  
Prognostic Value ◽  
Colon Adenocarcinoma ◽  
Regulatory Factors ◽  
Interferon Regulatory Factors

Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Di Zhang ◽  
DanDan Zhang ◽  
Chen Wang ◽  
XiaoLi Yang ◽  
RongQiang Zhang ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Prognostic Value ◽  
Regulatory Factors

scholarly journals Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma

2018 ◽  
Vol Volume 10 ◽  
pp. 5807-5824 ◽  
Author(s):  
Shijun Wang ◽  
Qiaoqi Wang ◽  
Xiqian Zhang ◽  
Xiwen Liao ◽  
Guixian Wang ◽  
...  
Keyword(s):  
Prognostic Value ◽  
Colon Adenocarcinoma ◽  
Diagnostic Value

The Clinical Significance and Prognostic Value of HER2 Expression in Bladder Cancer: a Systematic Review and Meta-analysis

2020 ◽  
Author(s):  
Kai Gan ◽  
Yue Gao ◽  
KuangZheng Liu ◽  
Bin Xu ◽  
Ming Chen
Keyword(s):  
Bladder Cancer ◽  
Clinical Significance ◽  
Prognostic Value ◽  
Meta Analysis ◽  
Growth Factor Receptor ◽  
Tumor Stage ◽  
The Cancer Genome Atlas ◽  
Her2 Expression ◽  
Large Tumor ◽  
Normal Tissues

Abstract Objective: Human Epidermal Growth Factor Receptor 2 (HER2) is highly expressed in a variety of tumors and associated with patients’ prognosis, but its role in bladder cancer remains unclear. We conducted this meta-analysis to explore the clinical significance and prognostic value of HER2 in bladder cancer and its potentiality as an immunotherapy target.Methods: PubMed was searched for studies published between January 1, 2000 and January 1, 2020. The odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (95%CIs) were used to investigate the relationship between HER2 and bladder cancer. UALCAN website was used to obtain TCGA (The cancer genome atlas) database.Results: Our study includes 14 articles, 1398 patients. HER2 expression was significantly higher in bladder cancer than in normal tissues. Our meta-analysis results did not reveal any effect of gender on the expression of HER2 levels in bladder cancer patients. However, HER2 expression in male patients was significantly higher than that in women according to TCGA databases. HER2 expression was also associated with carcinoma in situ, multifocal tumors, large tumor size, high tumor stage and grade, lymph node metastases, risk of recurrence and progression, low recurrence-free survival (RFS) rate. HER2 expression status had no effect on overall survival.Conclusions: Our meta-analysis showed that HER2 expression was related to pathological malignancy and poor prognosis in bladder cancer which indicated that it could be used as an effective biomarker and therapeutic target.

Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis- infected synovial fibroblasts

1999 ◽  
Vol 187 (4) ◽  
pp. 205-212 ◽  
Author(s):  
J. Rödel ◽  
Annemarie Groh ◽  
Matthias Hartmann ◽  
Karl-Hermann Schmidt ◽  
Marc Lehmann ◽  
...  
Keyword(s):  
Chlamydia Trachomatis ◽  
Synovial Fibroblasts ◽  
Regulatory Factors ◽  
Indoleamine 2,3 Dioxygenase ◽  
Interferon Regulatory Factors
Sign in / Sign up

Export Citation Format

Share Document